FDA Inspection
Csl Plasma, Inc.Csl Plasma, Inc. – FDA Inspection, Feb 26, 2025
Record Details
This FDA Inspection record concerns Csl Plasma, Inc., with an inspection on February 26, 2025, issued by the Minneapolis District Office, covering biologics.
View Company Profile
ID · 04988184-c18f-4d10-b63d-731b37b375ea
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1262061
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Csl Plasma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 8, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 30, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 3, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 20, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Csl Plasma, Inc.
- FDA Inspection 1062734 - 2018-07-18
- FDA Inspection 958032 - 2016-01-08
- FDA Inspection 889317 - 2014-07-30
- FDA Inspection 774819 - 2012-04-03
- FDA Inspection 643462 - 2010-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.